133 related articles for article (PubMed ID: 29843599)
1. JCDSA: a joint covariate detection tool for survival analysis on tumor expression profiles.
Wu Y; Liu Y; Wang Y; Shi Y; Zhao X
BMC Bioinformatics; 2018 May; 19(1):187. PubMed ID: 29843599
[TBL] [Abstract][Full Text] [Related]
2. Joint Covariate Detection on Expression Profiles for Selecting Prognostic miRNAs in Glioblastoma.
Sun C; Zhao X
Biomed Res Int; 2017; 2017():3017948. PubMed ID: 28409153
[TBL] [Abstract][Full Text] [Related]
3. JCD-DEA: a joint covariate detection tool for differential expression analysis on tumor expression profiles.
Li Y; Liu Y; Wu Y; Zhao X
BMC Bioinformatics; 2019 Jun; 20(1):365. PubMed ID: 31253075
[TBL] [Abstract][Full Text] [Related]
4. Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures.
Yerukala Sathipati S; Huang HL; Ho SY
BMC Genomics; 2016 Dec; 17(Suppl 13):1022. PubMed ID: 28155650
[TBL] [Abstract][Full Text] [Related]
5. Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients.
Qiu S; Lin S; Hu D; Feng Y; Tan Y; Peng Y
J Transl Med; 2013 Jan; 11():10. PubMed ID: 23302469
[TBL] [Abstract][Full Text] [Related]
6. Visualizing molecular profiles of glioblastoma with GBM-BioDP.
Celiku O; Johnson S; Zhao S; Camphausen K; Shankavaram U
PLoS One; 2014; 9(7):e101239. PubMed ID: 25010047
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous miRNA and mRNA transcriptome profiling of glioblastoma samples reveals a novel set of OncomiR candidates and their target genes.
Gulluoglu S; Tuysuz EC; Sahin M; Kuskucu A; Kaan Yaltirik C; Ture U; Kucukkaraduman B; Akbar MW; Gure AO; Bayrak OF; Dalan AB
Brain Res; 2018 Dec; 1700():199-210. PubMed ID: 30176243
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.
Henriksen M; Johnsen KB; Andersen HH; Pilgaard L; Duroux M
Mol Neurobiol; 2014 Dec; 50(3):896-913. PubMed ID: 24619503
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Glioblastoma Patients' Plasma Revealed the Presence of MicroRNAs with a Prognostic Impact on Survival and Those of Viral Origin.
Herman A; Gruden K; Blejec A; Podpečan V; Motaln H; Rožman P; Hren M; Zupančič K; Veber M; Verbovšek U; Lah Turnšek T; Porčnik A; Koršič M; Knežević M; Jeras M
PLoS One; 2015; 10(5):e0125791. PubMed ID: 25950799
[TBL] [Abstract][Full Text] [Related]
10. Stepwise detection and evaluation reveal miR-10b and miR-222 as a remarkable prognostic pair for glioblastoma.
Sun B; Zhao X; Ming J; Liu X; Liu D; Jiang C
Oncogene; 2019 Aug; 38(33):6142-6157. PubMed ID: 31289362
[TBL] [Abstract][Full Text] [Related]
11. Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients.
Sana J; Radova L; Lakomy R; Kren L; Fadrus P; Smrcka M; Besse A; Nekvindova J; Hermanova M; Jancalek R; Svoboda M; Hajduch M; Slampa P; Vyzula R; Slaby O
Carcinogenesis; 2014 Dec; 35(12):2756-62. PubMed ID: 25322872
[TBL] [Abstract][Full Text] [Related]
12. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
[TBL] [Abstract][Full Text] [Related]
13. A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer.
Fatai AA; Gamieldien J
BMC Cancer; 2018 Apr; 18(1):377. PubMed ID: 29614978
[TBL] [Abstract][Full Text] [Related]
14. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of micro-RNA, gene expression, and survival of glioblastoma multiforme.
Huang YT; Hsu T; Kelsey KT; Lin CL
Genet Epidemiol; 2015 Feb; 39(2):134-43. PubMed ID: 25537983
[TBL] [Abstract][Full Text] [Related]
16. A 4-miRNAs signature predicts survival in glioblastoma multiforme patients.
Yuan GQ; Wei NL; Mu LY; Wang XQ; Zhang YN; Zhou WN; Pan YW
Cancer Biomark; 2017 Dec; 20(4):443-452. PubMed ID: 28869437
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression signatures and their correlation with clinicopathological features in glioblastoma multiforme.
Henriksen M; Johnsen KB; Olesen P; Pilgaard L; Duroux M
Neuromolecular Med; 2014 Sep; 16(3):565-77. PubMed ID: 24817689
[TBL] [Abstract][Full Text] [Related]
19. Propolis Extract Regulates microRNA Expression in Glioblastoma and Brain Cancer Stem Cells.
C Yilmaz U; Bagca BG; Karaca E; Durmaz A; Durmaz B; Aykut A; Kayalar H; Avci CB; Susluer SY; Pariltay E; Gunduz C; Cogulu O
Anticancer Agents Med Chem; 2022; 22(2):378-389. PubMed ID: 33949939
[TBL] [Abstract][Full Text] [Related]
20. MiR-328 expression is decreased in high-grade gliomas and is associated with worse survival in primary glioblastoma.
Wu Z; Sun L; Wang H; Yao J; Jiang C; Xu W; Yang Z
PLoS One; 2012; 7(10):e47270. PubMed ID: 23077581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
